Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Shares Outstanding (Diluted Average) (2019 - 2025)

Inspire Medical Systems (INSP) has disclosed Shares Outstanding (Diluted Average) for 7 consecutive years, with $29.8 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) fell 2.57% to $29.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $29.8 million through Dec 2025, down 2.57% year-over-year, with the annual reading at $29.8 million for FY2025, 2.57% down from the prior year.
  • Shares Outstanding (Diluted Average) hit $29.8 million in Q4 2025 for Inspire Medical Systems, down from $29.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $30.6 million in Q3 2024 to a low of $27.1 million in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $28.9 million across 5 years, with a median of $29.2 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): rose 7.94% in 2021 and later dropped 2.65% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $27.3 million in 2021, then grew by 2.97% to $28.1 million in 2022, then grew by 4.38% to $29.3 million in 2023, then increased by 4.24% to $30.5 million in 2024, then dropped by 2.57% to $29.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for INSP at $29.8 million in Q4 2025, $29.9 million in Q3 2025, and $29.6 million in Q2 2025.